Alzheimer's Drug Discovery Foundation - NEuroimaging and CSF Biomarker Program

The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. Biomarkers should have clear advantages over other relevant biomarkers as well as a path to commercialization and/or clinical use. 

Apply Now